Michael Ferguson
Corporate Officer/Principal chez ABIVAX
Profil
Michael Ferguson is currently the Chief Commercial Officer at Abivax SA. He holds an MBA from The Pennsylvania State University and an undergraduate degree from St. Joseph's University.
Postes actifs de Michael Ferguson
| Sociétés | Poste | Début |
|---|---|---|
| ABIVAX | Corporate Officer/Principal | 18/04/2023 |
Anciens postes connus de Michael Ferguson
| Sociétés | Poste | Fin |
|---|---|---|
| ARENA PHARMACEUTICALS | Corporate Officer/Principal | 01/05/2022 |
Formation de Michael Ferguson
| The Pennsylvania State University | Masters Business Admin |
| St. Joseph's University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABIVAX | Health Technology |
| Entreprise privées | 1 |
|---|---|
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
